Menstrual Cycle and Women's Performance

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-35
SponsorCharles University, Czech Republic

About this trial

This study examines how different phases of the menstrual cycle are associated with selected performance and musculoskeletal parameters in physically active women aged 18-35 years.

Participants will track their menstrual cycle using a mobile app for approximately 2 months and attend 3 laboratory visits scheduled to specific cycle phases.

At each visit, participants will complete non-invasive assessments including lower-limb strength/performance testing, musculoskeletal measurements (muscle and tendon properties), body composition assessment, and symptom-related questionnaires.

The goal is to improve understanding of physiological variability across the menstrual cycle and support evidence-based planning of training, testing, and clinical practice in women.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Female, age 18-35 years

Disqualifiers

Irregular menstrual cycle (outside protocol-defined regularity)

Trial population

Premenopausal women aged 18-35 years from the general population with occasional to recreational physical activity, recruited for repeated within-subject assessments across predefined menstrual cycle phases.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Menstrual Cycle Tracking

    Other intervention

    Menstrual cycle monitoring using a mobile application for approximately 2 months to schedule laboratory visits to predefined cycle phases.

  • Performance and Strength Testing

    Other intervention

    Repeated lower-limb performance/strength assessments during laboratory visits in different menstrual cycle phases.

  • Musculoskeletal Assessment

    Other intervention

    Non-invasive assessment of selected muscle and tendon mechanical properties across cycle phases.

  • Body Composition and Symptom Assessment

    Other intervention

    Body composition measurement and collection of self-reported menstrual-related symptoms at laboratory visits.

Treatment groups

32 Participants
are divided into 1 treatment group
Group A: Physically Active Women (18-35 years)4 interventions

Trial outcomes

Primary outcomes

1

Phase-specific change in lower-limb neuromuscular performance across the menstrual cycle

Within-subject differences in lower-limb performance/strength outcomes measured during three laboratory visits scheduled to predefined menstrual cycle phases.

Time frame
Assessed at 3 laboratory visits across approximately 2 months (cycle tracking period)

Secondary outcomes

1

Phase-specific differences in muscle mechanical properties

Within-subject changes in selected skeletal muscle mechanical properties measured non-invasively across predefined menstrual cycle phases.

Time frame
Assessed at 3 laboratory visits across approximately 2 months
2

Phase-specific differences in tendon mechanical properties

Within-subject changes in selected tendon mechanical properties measured non-invasively across predefined menstrual cycle phases.

Time frame
Assessed at 3 laboratory visits across approximately 2 months
3

Phase-specific differences in body composition variables

Within-subject differences in body composition parameters assessed at laboratory visits scheduled to predefined menstrual cycle phases.

Time frame
Assessed at 3 laboratory visits across approximately 2 months
4

Menstrual-related symptom profile across menstrual cycle phases

Self-reported menstrual-related symptoms recorded via questionnaires/standardized symptom reporting and compared across predefined cycle phases.

Time frame
Collected during cycle tracking and at 3 laboratory visits across approximately 2 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: